View all cases
UPC APP 16306/2025
EP4183412 Unitary patent · RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
- Case details
- StatusWithdrawnActionProcedural applicationCategoryWithdrawal applications
- Parties
- Claimants
- GlaxoSmithKline Biologicals SAOperating co.
Representatives- Oliver Jan Jüngst-Bird & Bird LLP
- Luca Brons-Bird & Bird LLP
- Daniela Kinkeldeysupporting-Bird & Bird LLP
- Anna Schadelsupporting-Bird & Bird LLP
Respondents- Pfizer Europe MA EEIGOperating co.
- Pfizer Manufacturing Belgium NVOperating co.
- Pfizer Pharma GmbHOperating co.
- Pfizer Corporation Austria GmbHOperating co.
- Pfizer S.A.Operating co.
- Pfizer ApSOperating co.
- Pfizer OyOperating co.
- Pfizer SASOperating co.
- Pfizer S.r.l.Operating co.
- Pfizer B.V.Operating co.
- Laboratórios Pfizer, Lda.Operating co.
- Pfizer ABOperating co.
- Pfizer Luxembourg SARLOperating co.
- Pfizer Service Company S.R.L.Operating co.
Representatives- Gareth Williams-Marks & Clerk LLP
- Claudia Milbradt-Clifford Chance Partnerschaft mbB
- Tobias J. Hessel-Clifford Chance Partnerschaft mbB
- Division
- Dusseldorf LD
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- Language
- —
- First decided
- Apr 11, 2025
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Dusseldorf LD | Locked |
| Judge Jule Schumacher | Locked |
| Judge Andrea Postiglione | Locked |
| Judge Steen Wadskov-Hansen | Locked |
At the UPC: GlaxoSmithKline Biologicals SA (20 cases)·Pfizer Group (31 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 8 other proceedings
UPC CFI 687/2024·UPC CFI 476/2024·UPC CFI 468/2024·UPC APP 16366/2025·UPC APP 17607/2025 and 3 more
Start a free trial to see how each one ended.
More cases: Dusseldorf LD·2025
Decisions
- 2025-04-11Application RoP 265Public
Summary: The Düsseldorf Local Division allowed GlaxoSmithKline Biologicals SA's withdrawal of its infringement action against Pfizer entities concerning EP 4 183 412 with the consent of all defendants, declared the proceedings closed, and ordered reimbursement of 60% of court fees amounting to EUR 201,600.
Show the legal issues (2)
- Withdrawal of infringement action (R. 265.1 RoP)
- Reimbursement of court fees (R. 370 RoP)
Documents
- 2EB3BC86B1C2E383E6DDA311770590D1_en.pdf2025-04-11EN